These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

622 related items for PubMed ID: 16322132

  • 21. Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey.
    Ozdemir H, Ciftçi E, Tapisiz A, Ince E, Tutar E, Atalay S, Dogru U.
    J Trop Pediatr; 2010 Aug; 56(4):260-2. PubMed ID: 20007257
    [Abstract] [Full Text] [Related]

  • 22. Kawasaki disease.
    Gouveia C, Brito MJ, Ferreira GC, Ferreira M, Nunes MA, Machado Mdo C.
    Rev Port Cardiol; 2005 Sep; 24(9):1097-113. PubMed ID: 16335284
    [Abstract] [Full Text] [Related]

  • 23. Characteristics of Kawasaki disease in infants younger than six months of age.
    Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH.
    Pediatr Infect Dis J; 2006 Mar; 25(3):241-4. PubMed ID: 16511387
    [Abstract] [Full Text] [Related]

  • 24. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
    Uehara R, Belay ED, Maddox RA, Holman RC, Nakamura Y, Yashiro M, Oki I, Ogino H, Schonberger LB, Yanagawa H.
    Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
    [Abstract] [Full Text] [Related]

  • 25. [Kawasaki disease: clinical characteristics and cardiovascular involvement in a cohort of 121 patients].
    Calabri GB, Falcini F, Favilli S, Pollini I, Capuzzo L, Simonini G, De Simone L.
    Pediatr Med Chir; 2002 Feb; 24(5):352-7; discussion 397-9. PubMed ID: 12494535
    [Abstract] [Full Text] [Related]

  • 26. [Kawasaki disease: what you need to know].
    Bajolle F, Laux D.
    Arch Pediatr; 2012 Nov; 19(11):1264-8. PubMed ID: 22921712
    [Abstract] [Full Text] [Related]

  • 27. Prognostic impact of vascular leakage in acute Kawasaki disease.
    Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y.
    Circulation; 2003 Jul 22; 108(3):325-30. PubMed ID: 12835221
    [Abstract] [Full Text] [Related]

  • 28. [Clinical features of recurrent Kawasaki disease in 20 children].
    Zou LX, Gong FQ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct 22; 10(5):617-9. PubMed ID: 18947484
    [Abstract] [Full Text] [Related]

  • 29. Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression.
    Millar K, Manlhiot C, Yeung RS, Somji Z, McCrindle BW.
    Int J Cardiol; 2012 Jan 12; 154(1):9-13. PubMed ID: 20851480
    [Abstract] [Full Text] [Related]

  • 30. Kawasaki disease: diagnosis, management, and long-term implications.
    Satou GM, Giamelli J, Gewitz MH.
    Cardiol Rev; 2007 Jan 12; 15(4):163-9. PubMed ID: 17575479
    [Abstract] [Full Text] [Related]

  • 31. Fulfillment of diagnostic criteria in Kawasaki disease.
    Stapp J, Marshall GS.
    South Med J; 2000 Jan 12; 93(1):44-7. PubMed ID: 10653064
    [Abstract] [Full Text] [Related]

  • 32. [Early diagnosis of Kawasaki disease complicated by coronary artery lesions].
    Hu XH, Xu SX, Luan Z.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug 12; 23(8):853-5. PubMed ID: 12919919
    [Abstract] [Full Text] [Related]

  • 33. Kawasaki disease: part II. Complications and treatment.
    Bayers S, Shulman ST, Paller AS.
    J Am Acad Dermatol; 2013 Oct 12; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380
    [Abstract] [Full Text] [Related]

  • 34. Treatment of Kawasaki disease using locally product intravenous immunoglobulin.
    Sangtawesin C, Kirawitaya T, Layangkool T, Nawasiri W, Vimolsarawong N.
    J Med Assoc Thai; 2003 Aug 12; 86 Suppl 3():S656-60. PubMed ID: 14700163
    [Abstract] [Full Text] [Related]

  • 35. Pattern of clinical features of Kawasaki disease.
    Muzaffer MA, Al-Mayouf SM.
    Saudi Med J; 2002 Apr 12; 23(4):409-12. PubMed ID: 11953766
    [Abstract] [Full Text] [Related]

  • 36. Lack of association of cervical lymphadenopathy and coronary artery complications in Kawasaki disease.
    Sung RY, Ng YM, Choi KC, Mok GC, Cheng YW, Ho MH, Hong Kong Kawasaki Disease Study Group.
    Pediatr Infect Dis J; 2006 Jun 12; 25(6):521-5. PubMed ID: 16732150
    [Abstract] [Full Text] [Related]

  • 37. [Kawasaki disease in children--9 years experience].
    Kowalczyk M, Kawalec W, Daszkowska-York J, Turska-Kmieć A, Brzezińska-Rajszys G, Sobielarska D, Ziółkowska L, Kościesza A, Jagiełłowicz D, Mirecka-Rola A.
    Med Wieku Rozwoj; 2005 Jun 12; 9(2):179-93. PubMed ID: 16085959
    [Abstract] [Full Text] [Related]

  • 38. Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease.
    Lee TJ, Kim KH, Chun JK, Kim DS.
    Yonsei Med J; 2008 Oct 31; 49(5):714-8. PubMed ID: 18972590
    [Abstract] [Full Text] [Related]

  • 39. Infliximab as a novel therapy for refractory Kawasaki disease.
    Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS.
    J Rheumatol; 2004 Apr 31; 31(4):808-10. PubMed ID: 15088313
    [Abstract] [Full Text] [Related]

  • 40. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications.
    De Rosa G, Pardeo M, Rigante D.
    Eur Rev Med Pharmacol Sci; 2007 Apr 31; 11(5):301-8. PubMed ID: 18074939
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.